801P - Efficacy and safety of trifluridine/tipiracil (FTD/TPI) in European patients with heavily pretreated metastatic gastric cancer (mGC): An analysis of the TAGS study

M Alsina,J Tabernero,H.-T Arkenau,M Squadroni,T Doi,C Faustino,M Ghidini,W Mansoor,K Shitara,E Van Cutsem,N Causse-Amellal,C Leger,D Skanji,D Ilson

doi:10.1093/annonc/mdz247.127

801P - Efficacy and safety of trifluridine/tipiracil (FTD/TPI) in European patients with heavily pretreated metastatic gastric cancer (mGC): An analysis of the TAGS study

M Alsina, J Tabernero + Show 12 more

Open Access

https://doi.org/10.1093/annonc/mdz247.127

Copy DOI

Journal: Annals of oncology : official journal of the European Society for Medical Oncology	Publication Date: Oct 1, 2019
License type: publisher-specific-oa

Affiliation: Vall d'Hebron Institute of Oncology, National Cancer Center Hospital East, KU Leuven

#Research Grant #Taiho Pharmaceutical + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

801P - Efficacy and safety of trifluridine/tipiracil (FTD/TPI) in European patients with heavily pretreated metastatic gastric cancer (mGC): An analysis of the TAGS study

Full Text